Author

Eden N. Gordon

Tango Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Alan HuangiD· 1 shared Ashley H. ChoiiD· 1 shared Binzhang SheniD· 1 shared Catherine M. GorickiD· 1 shared Charlotte B. PrattiD· 1 shared Chengyin MiniD· 1 shared Claire A ConarroeiD· 1 shared Hannah StoweiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alan HuangORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Focused Ultrasound Blood-Tumor Barrier Opening Rapidly Augments Intratumor CD4 and CD8 T Cell Representation in a Genetically Engineered Mouse Model of Glioma

Katherine M. Nowak, Matthew R. Hoch, William B. Gillespie, Claire A Conarroe, Victoria R. Breza, Tanya Cruz, Eden N. Gordon, Catherine M. Gorick, Tajie H. Harris, Joshua D. Wythe, Richard J. Price

This study shows that focused ultrasound with microbubbles opens the blood-tumor barrier in a glioma model, increasing CD4 and CD8 T cell infiltration without altering the CD8/Treg ratio.

bioRxiv · Jul 28, 2026 · PreprintCancer Biology

Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancer

Hongxiang Zhang, Matthew R. Tonini, Lauren Catherine M. Martires, Helena N. Jenkins, Charlotte B. Pratt, Eden N. Gordon, Shan-Chuan Zhao, Ashley H. Choi, Samuel R. Meier, Tenzing Khendu, Shangtao Liu, Binzhang Shen, Hannah Stowe, Katerina Pashiardis, Xuewen Pan, , Teng Teng

The paper identifies HBS1L as a synthetic lethal target in FOCAD-deleted cancer through combinatorial CRISPR screens and validates its dependency via genetic manipulation and in vivo experiments.

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · Oct 15, 2025Peer-reviewedCancer Biology